Dinkova-Kostova AT et al. |
Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers. |
1998 |
J. Med. Chem. |
pmid:9857096
|
Li H et al. |
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. |
2006 |
J. Mol. Graph. Model. |
pmid:16497524
|
Wu Y et al. |
Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines. |
2016 |
J. Mol. Med. |
pmid:26383911
|
Chen X et al. |
Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling. |
2012 |
J. Mol. Med. |
pmid:22648519
|
Peng F et al. |
Cytotoxic Evaluation against Breast Cancer Cells of Isoliquiritigenin Analogues from Spatholobus suberectus and Their Synthetic Derivatives. |
2016 |
J. Nat. Prod. |
pmid:26690274
|
Youn UJ et al. |
Identification of antiadipogenic constituents of the rhizomes of Anemarrhena asphodeloides. |
2009 |
J. Nat. Prod. |
pmid:19757853
|
Feldman M et al. |
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential. |
2011 |
J. Nat. Prod. |
pmid:21866899
|
Deng Y et al. |
Anthraquinones with quinone reductase-inducing activity and benzophenones from Morinda citrifolia (noni) roots. |
2007 |
J. Nat. Prod. |
pmid:18076142
|
Cuendet M et al. |
Quinone reductase induction as a biomarker for cancer chemoprevention. |
2006 |
J. Nat. Prod. |
pmid:16562858
|
Boyapelly K et al. |
Synthesis and Characterization of a Phosphate Prodrug of Isoliquiritigenin. |
2017 |
J. Nat. Prod. |
pmid:28252963
|
Kwon GT et al. |
Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. |
2009 |
J. Nutr. Biochem. |
pmid:18824345
|
Kang SW et al. |
Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases. |
2010 |
J. Nutr. Biochem. |
pmid:19157825
|
Jung JI et al. |
Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. |
2006 |
J. Nutr. Biochem. |
pmid:16517140
|
Yerra VG et al. |
Isoliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy. |
2017 |
J. Nutr. Biochem. |
pmid:28528294
|
Sun ZJ et al. |
Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. |
2010 |
J. Pharmacol. Exp. Ther. |
pmid:20484154
|
Noguchi C et al. |
Inhibitory effects of isoliquiritigenin and licorice extract on voltage-dependent K(+) currents in H9c2 cells. |
2008 |
J. Pharmacol. Sci. |
pmid:19098391
|
Lee MJ et al. |
Protective effects of isoliquiritigenin against methamphetamine-induced neurotoxicity in mice. |
2009 |
J. Pharmacol. Sci. |
pmid:19834288
|
Lee CK et al. |
Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma. |
2008 |
J. Pharmacol. Sci. |
pmid:18360095
|
Muanprasat C et al. |
Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease. |
2012 |
J. Pharmacol. Sci. |
pmid:22186622
|
Jeon JP et al. |
Proteomic and behavioral analysis of response to isoliquiritigenin in brains of acute cocaine treated rats. |
2008 |
J. Proteome Res. |
pmid:19367698
|